InspireMD Historical Financial Ratios

NSPR Stock

USD 3.00 0.02 0.67%

InspireMD is lately reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 129 will help investors to properly organize and evaluate InspireMD financial condition quickly.

Quick Ratio Current Ratio

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

About InspireMD Financial Ratios Analysis

InspireMDFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate InspireMD investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on InspireMD financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across InspireMD history.

InspireMD Financial Ratios Chart

At this time, InspireMD's Current Ratio is relatively stable compared to the past year. As of 12/23/2024, Tangible Book Value Per Share is likely to grow to 1.71, while Days Sales Outstanding is likely to drop 129.34.

Days Sales Outstanding Free Cash Flow Per Share Inventory Turnover Ev To Free Cash Flow Enterprise Value Over E B I T D A Long Term Debt To Capitalization

Add Fundamental

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Most ratios from InspireMD's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into InspireMD current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.At this time, InspireMD's Current Ratio is relatively stable compared to the past year. As of 12/23/2024, Tangible Book Value Per Share is likely to grow to 1.71, while Days Sales Outstanding is likely to drop 129.34.

	2021	2022	2023	2024 (projected)
Payables Turnover	4.19	6.15	4.68	3.75
Days Of Inventory On Hand	111.52	145.95	174.78	198.81

Payables Turnover Days Of Inventory On Hand

InspireMD fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		1.0	0.15	0.16	0.19	0.19	0.43	1.0	1.0	0.17	-0.4	-0.21	0.19	0.17	0.25	0.06	-0.2	-1.0	0.19	-0.39	-1.0	-0.23	-0.52	-0.14	-1.0	-1.0
Ptb Ratio	1.0		0.14	0.14	0.17	0.17	0.42	1.0	1.0	0.15	-0.42	-0.21	0.17	0.17	0.25	0.06	-0.18	-1.0	0.23	-0.38	-1.0	-0.22	-0.52	-0.14	-1.0	-1.0
Days Sales Outstanding	0.15	0.14		-0.31	0.43	-0.28	0.07	0.14	0.15	-0.47	0.24	-0.67	-0.28	0.69	-0.17	-0.08	0.23	-0.14	0.19	-0.18	-0.14	0.48	-0.71	-0.24	-0.14	-0.14
Book Value Per Share	0.16	0.14	-0.31		0.11	0.98	0.4	0.14	0.15	0.91	0.37	0.34	0.98	-0.48	0.46	0.3	-0.92	-0.15	-0.53	-0.4	-0.15	-0.67	0.39	-0.45	-0.14	-0.15
Free Cash Flow Yield	0.19	0.17	0.43	0.11		0.27	0.55	0.17	0.18	0.03	0.49	-0.66	0.26	0.46	0.05	0.27	-0.4	-0.17	-0.42	-0.51	-0.17	0.07	-0.27	-0.28	-0.17	-0.17
Operating Cash Flow Per Share	0.19	0.17	-0.28	0.98	0.27		0.5	0.17	0.18	0.92	0.37	0.26	1.0	-0.43	0.53	0.37	-0.98	-0.17	-0.62	-0.49	-0.17	-0.71	0.37	-0.44	-0.17	-0.17
Capex To Depreciation	0.43	0.42	0.07	0.4	0.55	0.5		0.42	0.43	0.36	0.15	-0.04	0.5	-0.07	0.25	0.76	-0.57	-0.42	-0.41	-0.91	-0.42	-0.33	-0.18	-0.4	-0.42	-0.42
Pb Ratio	1.0	1.0	0.14	0.14	0.17	0.17	0.42		1.0	0.15	-0.42	-0.21	0.17	0.17	0.25	0.06	-0.18	-1.0	0.23	-0.38	-1.0	-0.22	-0.52	-0.14	-1.0	-1.0
Ev To Sales	1.0	1.0	0.15	0.15	0.18	0.18	0.43	1.0		0.16	-0.41	-0.21	0.18	0.17	0.24	0.06	-0.19	-1.0	0.19	-0.39	-1.0	-0.23	-0.53	-0.13	-1.0	-1.0
Free Cash Flow Per Share	0.17	0.15	-0.47	0.91	0.03	0.92	0.36	0.15	0.16		0.12	0.46	0.92	-0.62	0.61	0.21	-0.9	-0.15	-0.57	-0.32	-0.15	-0.85	0.43	-0.3	-0.15	-0.15
Roic	-0.4	-0.42	0.24	0.37	0.49	0.37	0.15	-0.42	-0.41	0.12		-0.15	0.37	-0.02	-0.16	0.2	-0.34	0.41	-0.49	-0.2	0.41	0.25	0.16	-0.54	0.42	0.42
Inventory Turnover	-0.21	-0.21	-0.67	0.34	-0.66	0.26	-0.04	-0.21	-0.21	0.46	-0.15		0.27	-0.94	0.23	0.24	-0.19	0.21	-0.17	0.01	0.21	-0.43	0.6	-0.09	0.21	0.21
Net Income Per Share	0.19	0.17	-0.28	0.98	0.26	1.0	0.5	0.17	0.18	0.92	0.37	0.27		-0.44	0.52	0.37	-0.98	-0.17	-0.61	-0.49	-0.17	-0.71	0.37	-0.45	-0.17	-0.17
Days Of Inventory On Hand	0.17	0.17	0.69	-0.48	0.46	-0.43	-0.07	0.17	0.17	-0.62	-0.02	-0.94	-0.44		-0.3	-0.24	0.37	-0.17	0.34	0.09	-0.17	0.5	-0.6	0.26	-0.17	-0.17
Payables Turnover	0.25	0.25	-0.17	0.46	0.05	0.53	0.25	0.25	0.24	0.61	-0.16	0.23	0.52	-0.3		0.28	-0.56	-0.25	-0.37	-0.19	-0.25	-0.83	0.26	-0.07	-0.25	-0.25
Capex To Revenue	0.06	0.06	-0.08	0.3	0.27	0.37	0.76	0.06	0.06	0.21	0.2	0.24	0.37	-0.24	0.28		-0.42	-0.06	-0.48	-0.77	-0.06	-0.28	0.25	-0.25	-0.06	-0.06
Cash Per Share	-0.2	-0.18	0.23	-0.92	-0.4	-0.98	-0.57	-0.18	-0.19	-0.9	-0.34	-0.19	-0.98	0.37	-0.56	-0.42		0.18	0.67	0.56	0.18	0.72	-0.34	0.42	0.18	0.18
Pocfratio	-1.0	-1.0	-0.14	-0.15	-0.17	-0.17	-0.42	-1.0	-1.0	-0.15	0.41	0.21	-0.17	-0.17	-0.25	-0.06	0.18		-0.22	0.38	1.0	0.22	0.52	0.14	1.0	1.0
Interest Coverage	0.19	0.23	0.19	-0.53	-0.42	-0.62	-0.41	0.23	0.19	-0.57	-0.49	-0.17	-0.61	0.34	-0.37	-0.48	0.67	-0.22		0.36	-0.22	0.5	-0.46	0.05	-0.23	-0.23
Capex To Operating Cash Flow	-0.39	-0.38	-0.18	-0.4	-0.51	-0.49	-0.91	-0.38	-0.39	-0.32	-0.2	0.01	-0.49	0.09	-0.19	-0.77	0.56	0.38	0.36		0.38	0.22	0.23	0.57	0.38	0.38
Pfcf Ratio	-1.0	-1.0	-0.14	-0.15	-0.17	-0.17	-0.42	-1.0	-1.0	-0.15	0.41	0.21	-0.17	-0.17	-0.25	-0.06	0.18	1.0	-0.22	0.38		0.22	0.52	0.14	1.0	1.0
Days Payables Outstanding	-0.23	-0.22	0.48	-0.67	0.07	-0.71	-0.33	-0.22	-0.23	-0.85	0.25	-0.43	-0.71	0.5	-0.83	-0.28	0.72	0.22	0.5	0.22	0.22		-0.45	-0.08	0.22	0.22
Income Quality	-0.52	-0.52	-0.71	0.39	-0.27	0.37	-0.18	-0.52	-0.53	0.43	0.16	0.6	0.37	-0.6	0.26	0.25	-0.34	0.52	-0.46	0.23	0.52	-0.45		0.22	0.52	0.52
Roe	-0.14	-0.14	-0.24	-0.45	-0.28	-0.44	-0.4	-0.14	-0.13	-0.3	-0.54	-0.09	-0.45	0.26	-0.07	-0.25	0.42	0.14	0.05	0.57	0.14	-0.08	0.22		0.14	0.14
Ev To Operating Cash Flow	-1.0	-1.0	-0.14	-0.14	-0.17	-0.17	-0.42	-1.0	-1.0	-0.15	0.42	0.21	-0.17	-0.17	-0.25	-0.06	0.18	1.0	-0.23	0.38	1.0	0.22	0.52	0.14		1.0
Pe Ratio	-1.0	-1.0	-0.14	-0.15	-0.17	-0.17	-0.42	-1.0	-1.0	-0.15	0.42	0.21	-0.17	-0.17	-0.25	-0.06	0.18	1.0	-0.23	0.38	1.0	0.22	0.52	0.14	1.0

Click cells to compare fundamentals

InspireMD Account Relationship Matchups

InspireMD fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	0.61	3.1	4.94	1.31	10.99	10.44
Days Sales Outstanding	95.44	138.8	112.79	88.02	144.24	129.34
Book Value Per Share	38.63	8.04	4.56	2.21	1.63	1.71
Free Cash Flow Yield	(4.47)	(1.19)	(0.61)	(2.37)	(0.25)	(0.26)
Operating Cash Flow Per Share	(70.41)	(6.0)	(1.8)	(1.97)	(0.67)	(0.71)
Capex To Depreciation	1.8	0.58	2.14	2.52	1.64	1.01
Free Cash Flow Per Share	(72.45)	(6.06)	(1.85)	(2.03)	(0.69)	(0.73)
Roic	(1.83)	(0.85)	(0.44)	(1.08)	(0.54)	(0.56)
Inventory Turnover	2.4	1.7	3.27	2.5	2.09	1.9
Net Income Per Share	(72.06)	(6.97)	(2.03)	(2.35)	(0.82)	(0.86)
Days Of Inventory On Hand	152.16	215.02	111.52	145.95	174.78	198.81
Payables Turnover	4.59	10.18	4.19	6.15	4.68	3.75
Sales General And Administrative To Revenue	1.4	2.47	1.65	1.62	1.79	2.31
Research And Ddevelopement To Revenue	0.79	0.9	1.15	1.51	1.29	0.86
Capex To Revenue	0.0763	0.0354	0.0765	0.0915	0.0614	0.0402
Cash Per Share	39.58	8.36	4.63	2.26	1.61	1.53
Pocfratio	(0.23)	(0.85)	(1.68)	(0.44)	(4.16)	(4.37)
Capex To Operating Cash Flow	(0.029)	(0.009691)	(0.026)	(0.0304)	(0.0233)	(0.0244)
Days Payables Outstanding	79.52	35.86	87.13	59.33	77.93	110.02
Income Quality	1.05	0.98	0.86	0.84	0.82	0.59
Roe	(1.87)	(0.87)	(0.44)	(1.06)	(0.5)	(0.48)
Ev To Free Cash Flow	0.26	0.43	(0.84)	(0.23)	(3.59)	(3.77)
Earnings Yield	(4.45)	(1.37)	(0.67)	(2.73)	(0.29)	(0.31)
Net Debt To E B I T D A	0.49	1.12	0.74	0.16	0.38	0.34
Current Ratio	2.51	4.14	8.53	4.21	7.34	7.7
Tangible Book Value Per Share	38.63	8.04	4.56	2.21	1.63	1.71
Receivables Turnover	3.82	2.63	3.24	4.15	2.53	2.6
Graham Number	250.28	35.52	14.44	10.81	5.48	5.21
Shareholders Equity Per Share	38.63	8.04	4.56	2.21	1.63	1.71
Capex Per Share	2.04	0.0582	0.0468	0.0601	0.0157	0.0149

Pair Trading with InspireMD

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InspireMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InspireMD will appreciate offsetting losses from the drop in the long position's value.

Moving together with InspireMD Stock

0.64	EW	Edwards Lifesciences Corp	Pair Corr
0.69	GH	Guardant Health	Pair Corr

Moving against InspireMD Stock

0.63	ENSG	Ensign Group	Pair Corr
0.62	DRIO	DarioHealth Corp	Pair Corr
0.6	EDAP	EDAP TMS SA	Pair Corr
0.49	VTAK	Catheter Precision	Pair Corr
0.49	EKSO	Ekso Bionics Holdings	Pair Corr

The ability to find closely correlated positions to InspireMD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InspireMD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InspireMD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InspireMD to buy it.

The correlation of InspireMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InspireMD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InspireMD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for InspireMD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

InspireMD Historical Financial Ratios

About InspireMD Financial Ratios Analysis

InspireMD Financial Ratios Chart

Free Cash Flow Per Share

Inventory Turnover

Ev To Free Cash Flow

InspireMD fundamentals Correlations

InspireMD Account Relationship Matchups

High Positive Relationship

High Negative Relationship

InspireMD fundamentals Accounts

Pair Trading with InspireMD

Moving together with InspireMD Stock

Moving against InspireMD Stock

Additional Tools for InspireMD Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ptb Ratio	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Price To Sales Ratio
Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Sales	+ 1.0	Ptb Ratio
Net Income Per Share	+ 1.0	Operating Cash Flow Per Share

Pe Ratio	- 1.0	Ev To Sales
Ev To Operating Cash Flow	- 1.0	Ev To Sales
Pfcf Ratio	- 1.0	Ev To Sales
Pocfratio	- 1.0	Ev To Sales
Pe Ratio	- 1.0	Pb Ratio
Ev To Operating Cash Flow	- 1.0	Pb Ratio